# Bone Health in Aging HIV Infected Women

> **NCT02815566** · PHASE4 · COMPLETED · sponsor: **University Health Network, Toronto** · enrollment: 34 (actual)

## Conditions studied

- Osteoporosis
- HIV
- Menopause

## Interventions

- **DRUG:** tenofovir-alafenamide-emtricitabine
- **DRUG:** tenofovir-emtricitabine

## Key facts

- **NCT ID:** NCT02815566
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-12
- **Primary completion:** 2021-02-25
- **Final completion:** 2021-02-25
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2024-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02815566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02815566, "Bone Health in Aging HIV Infected Women". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02815566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*